2A60

ICD-11 MMS 2026-01

Acute myeloid leukaemias and related precursor neoplasms

Description

Acute myeloid leukaemia is characterised by clonal expansion of myeloid blasts in the peripheral blood and bone marrow. Clinical manifestations are fever, pallor, anaemia, hemorrhages and recurrent infections.

Exclusions from above levels

  • 2E03 – Malignant neoplasm metastasis in bone or bone marrow
  • http://id.who.int/icd/entity/501778925 – Malignant neoplasm metastasis in lymph nodes
  • http://id.who.int/icd/entity/97145147 – Malignant neoplasm metastasis in thymus gland

Child codes

  • 2A60.0 – Acute myeloid leukaemia with recurrent genetic abnormalities
  • 2A60.1 – Acute myeloid leukaemia with myelodysplasia-related changes
  • 2A60.2 – Therapy-related myeloid neoplasms
  • 2A60.3 – Acute myeloid leukaemia, not elsewhere classified by criteria of other types
  • 2A60.4 – Myeloid proliferation associated with Down syndrome
  • 2A60.5 – Blastic plasmacytoid dendritic cell neoplasm
  • 2A60.Y – Other specified acute myeloid leukaemias and related precursor neoplasms
  • 2A60.Z – Acute myeloid leukaemias and related precursor neoplasms, unspecified

Sibling codes

  • 2A61 – Acute leukaemias of ambiguous lineage
  • 2B30 – Hodgkin lymphoma
  • 2B31 – Histiocytic or dendritic cell neoplasms
  • 2B32 – Immunodeficiency-associated lymphoproliferative disorders
  • 2B33 – Malignant haematopoietic neoplasms without further specification
  • 2B3Z – Neoplasms of haematopoietic or lymphoid tissues, unspecified

Foundation entity

Acute myeloid leukaemias and related precursor neoplasms – http://id.who.int/icd/entity/8864887

Allowed postcoordination axes

Part of: 02: Neoplasms